Not a healthcare professional? Go to the patient or caregiver website.

MYLOTARG™ Indications and Usage (gemtuzumab ozogamicin)

1 INDICATIONS AND USAGE

1.1 Newly-Diagnosed CD33-positive Acute Myeloid Leukemia (AML)

MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older.

1.2 Relapsed or Refractory CD33-positive AML

MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and pediatric patients 2 years and older.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No